Investing With IBD

Trade against the trend. Jason Shapiro, founder of Crowded Market Report, discusses how to properly diversify your portfolio with uncorrelated returns. Learn how to find setups in currencies like the sterling, yen and bitcoin, and why it’s OK to miss a trade. Learn more about your ad choices. Visit megaphone.fm/adchoices

Certain stocks and sectors are setting up to break out. But here’s the catch: they aren’t always showing up on the major indexes you’re watching. Mark Minervini, founder of Minervini Private Access, explains why this indicator tells you what the best names are doing and how to follow the money. Learn about why Insmed (INSM) stock is a buy-high-sell-higher opportunity, why Alpha and Omega Semicondu...

Sometimes you land the right stock, but at the wrong time. Other times, stocks get ahead of themselves. Trading pro David Ryan discusses how to identify stocks that need just a little more time to cook, and discusses strategies for dealing with names like Nvidia (NVDA), Ollie’s Bargain Outlet (OLLI) and Best Buy (BBY). Learn more about your ad choices. Visit megaphone.fm/adchoices

Kathy Donnelly, trader and co-author of “The Lifecycle Trade,” joins the podcast to discuss how she uses long-term hold rules to ride a winning stock to big gains. Learn how to preserve mental capital and hold through a pullback with examples from Nvidia (NVDA) and Microsoft (MSFT). Plus, we take a look at stocks setting up first stage bases including Reddit (RDDT), Robinhood (HOOD)and Arm Holding...

Mike Webster, senior market strategist at IBD, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss the current market and explain the dangers of downside reversals. Plus, we take a look at some stocks worthy of your watchlist including CrowdStrike (CRWD), ServiceNow (NOW) and Amazon (AMZN). Learn more about your ad choices. Visit megaphone.fm/adchoices

Market indecision can make money for savvy investors, but only if you’re able to act faster than the market. John Kosar, president and chief market strategist at Asbury Research, talks about modeling a unique period in the market and the contractions in models and rate cuts. Learn why volatility opens up opportunities in stocks like Apple (AAPL) and Microsoft (MSFT). Learn more about your ad choic...

It’s hard to sell when you’re making money — but that’s when sell rules matter the most. Joe Fahmy, portfolio manager at Zor Capital, joins Investor’s Business Daily’s “Investing with IBD” podcast to talk about selling strategies for winners, because they don't run forever, as well as laggards. Plus, he shares where he thinks we are in the current bull cycle and how much room Nvidia and other AI l...

Exploring the tricks, traps and tools behind the best trades. David Saito-Chung, deputy markets editor at IBD, joins Investor’s Business Daily’s “Investing with IBD” podcast to examine the rise (and decline) of Skechers, discuss why a distraction led Irusha to miss this stock’s run and how to trade in the spirit of Bill O’Neil. Learn more about your ad choices. Visit megaphone.fm/adchoices

Frothy sentiment and a market behaving the opposite of what’s expected is enough to worry even seasoned investors. Jeffrey Hirsch, editor of the Stock Trader’s Almanac, joins Investor’s Business Daily’s “Investing With IBD” podcast to talk about how historical models are impacting his election year outlook. While there might be some short-term chop, seasonality suggests a strong second half. Hirsc...

From Tesla (TSLA) to self driving, Elon Musk’s gravitational pull with investors is undeniable. But will AI dreams and automotive leadership be enough to overcome questions about Musk’s volatile management, the stock’s unrealized potential and a $46 billion pay raise request? Simon Erickson, founder and CEO of 7investing, joins Investor’s Business Daily’s “Investing with IBD” podcast to explain. L...

The market barometers are speaking — are you listening? Jim Roppel, founder of The Roppel Report, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss what major U.S. stocks, crypto and commodities are telling the market. Take an in-depth look at Amazon and Nvidia and learn why earnings from retailers around the world like MercadoLibre and PDD Holdings matter. Learn more about...

Katie Stockton, founder and managing partner of Fairlead Strategies, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss short-term market takeaways — and long-term momentum in stocks. Learn how to apply technical indicators to determine resistance levels in stocks like Amazon (AMZN) and why ETFs like VanEck Agribusiness (MOO) and stocks like General Mills (GIS) could be smar...

After years of hype, investors now want tech companies to show them the money. Jeremy C. Owens, tech editor at MarketWatch, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss earnings, AI and tech cycles. Learn why generative AI is in fact a story about business enterprise spending and why “The Trillionaires” like Microsoft (MSFT), Meta (META) and Alphabet (GOOGL) vary in th...

Don’t lower your standards. Dan Fitzpatrick joins Investor Business Daily’s “Investing with IBD” podcast to talk about taking a step back from the market, focusing on the leaders and why consistency is key in trading. Learn why Novo Nordisk (NVO) could be set to go higher and what’s great about Goldman Sachs (GS). Learn more about your ad choices. Visit megaphone.fm/adchoices

Everyone has different backgrounds, risk tolerances and psychologies. Tom Basso, enjoytheride.world founder and author, joins Investor Business Daily’s “Investing with IBD” podcast to discuss the simple foundations traders should modify and build upon to develop their own trading style. Learn about the differences — and similarities — between traders, and why he’s focused on the uptrends in gold a...

Turning down the volume. Mike Webster, senior market strategist at IBD, joins Investor’s Business Daily’s “Investing with IBD” podcast to explain why he thinks volume is problematic — and how he leverages insights from other chart elements to make buy, hold and sell decisions. Learn how doing your homework helps, the importance of price and why Inspire Medical Systems (INSP) and Cava (CAVA) are sh...

Bitcoin’s built-in supply control is nearly upon us and is set to reduce the reward for miners by half. But bitcoin is more than just the halving. Will Clemente, founder of Reflexivity Research, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss why institutions are offering bitcoin-exposed ETFs, Coinbase (COIN), and exactly how to value bitcoin in the first place. Plus, a l...

It’s usually considered a selling rule but is in fact more of a holding rule. Mike Webster, senior market strategist at IBD, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss his rule for adjusting a core position in a winning stock, no matter the market. Learn how to use regression channels for markets and relative strength line moving averages to keep positions in winning...

What causes markets to rise or fall doesn’t matter as much as you think. Irusha Peiris, O’Neil Global portfolio manager, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss the importance of focus, the value of rejecting market opinions and why interpreting is better than predicting markets. Peiris ends with a look at cybersecurity firm CrowdStrike (CRWD), homebuilder D.R. Ho...

It’s less about a market slump and more about a change in market leadership. David Keller, Chief Market Strategist at Stockcharts.com, joins Investor’s Business Daily’s “Investing with IBD” podcast to talk about how to think about sector rotation, growth and value stocks, and how the market is reacting to the Fed’s recent comments. He ends with a discussion of the surprising strengths in Duolingo...

Tom Dorsey, co-founder of Dorsey, Wright & Associates, is back to share his decades of experience in technical analysis. Dorsey popularized the point and figure method of charting and shares what he learned from his simple pencil-to-paper process. He sees striking similarities playing out that remind him of a 20-year bull market that started in 1982. So how far are we? Dorsey thinks we're just at...

The Ants Indicator, Earnings Line, fundamental data and more — it’s all there on MarketSurge. Scott St. Clair, premium product group manager at IBD, joins Investor’s Business Daily’s “Investing with IBD” podcast to talk about what’s new in IBD’s flagship stock charting software. Hear thoughts on Nvidia (NVDA) and analysis of the Amazon of international markets in stocks like SEA Limited (SE) and C...

From “fat-finger” trades of the decade to the big names moving off the Dow Jones Industrial Average. Jay Woods, chief global strategist at Freedom Capital Markets, joins Investor’s Business Daily’s “Investing with IBD” podcast to talk about going from a trading desk internship to Goldman Sachs and beyond. Learn the positives of healthcare investing in HCA Healthcare (HCA) and Stryker (SYK), and wh...

With megacap earnings like Nvidia still shaking markets, it’s time to read the signals. Is a stock climbing to the top … or on its way down? Eric Krull, co-author of “The Lifecycle Trade,” joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss climax signals, sell switches, and spotting “Mount Everests” in today’s markets. Krull also discusses strong signals and sell switches in...

Darling you’ve got to let me know. Irusha Peiris, O’Neil Global portfolio manager, joins Investor’s Business Daily’s “Investing with IBD” podcast for a special Valentine’s Day discussion. Whether the uptrend’s got you head-over-heels with your stock picks or just not feeling the same way about your portfolio, learn why it’s a good time for an (investment) relationship check, and why stocks like Ca...